Sun Protection Factor Assay (SPF Assay)
To evaluate the Sun protection factor efficacy on human skin.
- Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing. - Male and female - Aged between 18-70 years old. - Good health as determined from the HRL SHF(Self History Form) - Signed and dated Informed Consent Form - Signed and dated HIPAA (Health Insurance Portability and Accountability Act) Form - An unbambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose)
- Subjects on test at any other research laboratory or clinic. - Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light. - Pre-existing dermatologic conditions which have been diagnosed by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study. - Pre-existing other medical conditions (e.g. adult asthma. diabetes). - Treatment with antibiotics within two weeks prior to initiation of the test. - Chronic medication which could affect the results of the study. - Known pregnant or nursing women. - Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
Union, United States, 07083
E-mail: clinical-trials-con[email protected]
Phone: Not Available
Sun Protection Factor (SPF) Assay: UVA Protection Factor Assay (UVAPF), Minimal Persistent Pigment-Darkening Dose (MPPD)
Single Group Assignment